Betahistine-d3 |
|
Synonyms: N-(Methyl-d3)-2-pyridineethanamine; 2-[ß-(Methyl-d3)aminoethyl]pyridine; 2-[2-(Methyl-d3)aminoethyl]pyridine; Betahistine; N-(Methyl-d3)-N-[2-(pyridin-2-yl)ethyl]amine; NSC 42617-d3; Y-G 14-d3; [2-(2-Pyridyl)ethyl](methyl-d3)amine; | |
Cat. No.: B13020 | CAS No.: 244094-70-0/5638-76-6(unlabelled) |
MDL.: | Formula: C8H9D3N2 |
F.W.139.21 | Purity: 99% |
Storage: | |
  |

Catalog Number: | B13020 | CAS No.: | 244094-70-0/5638-76-6(unlabelled) | |
MDL: | Formula: | C8H9D3N2 | ||
F.W.: | 139.21 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Stability: | |||
Storage: | Category: | Reference Standard | ||
Reference: | Aantaa, E., et al.: Ann. Clin. Res., 8, 284 (1976), Arrang, J., et al.: Nature, 302, 832 (1983), Arrang, J., et al.: Eur. J. Pharmacol., 111, 73 (1985), Betts, T., et al.: Br. J. Clin. Pharmacol., 32, 455 (1991), Borel, L., et al.: Brain, 125, 880 (2002), | |||
Application: | It is used in the treatment of Meniere's disease. | |||
Category: | Aromatics, Heterocycles, Isotope Labelled Compounds, |